Ticker LaunchReverse merger · Completed · MYMD
MyMD Pharmaceuticals (Florida), Inc.
Reverse merger with Akers Biosciences, Inc. (AKER)
MyMD Pharmaceuticals (Florida), Inc. merged into Akers Biosciences, Inc. (AKER), a rapid health information technologies developer, in a reverse merger that takes the private company public. The deal was announced on Nov 11, 2020 and closed on Apr 16, 2021. The combined company trades as MyMD Pharmaceuticals, Inc. (MYMD) on Nasdaq.
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on extending healthy lifespan through two therapeutic platforms, including MYMD-1, a small molecule that regulates the immunometabolic system to control TNF-alpha.
- Status
- Completed
- Private company
- MyMD Pharmaceuticals (Florida), Inc.
- Public company
- Akers Biosciences, Inc. (AKER)
- Public company business before
- rapid health information technologies developer
- Announced
- Nov 11, 2020
- Closed
- Apr 16, 2021
- Combined company
- MyMD Pharmaceuticals, Inc. (MYMD)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Apr 22, 2021
- Closing press release / exhibit
- All filings on EDGAR CIK 1321834
Other completed reverse mergers
- Leading BioSciences, Inc.into Seneca Biopharma, Inc. · Apr 27, 2021
- Healthcare Solutions Holdings, Inc.into Verity Corp. · Apr 21, 2021
- 374Water Inc.into PowerVerde, Inc. · Apr 16, 2021
- StemoniX, Inc.into Cancer Genetics, Inc. · Mar 30, 2021
- Brooklyn ImmunoTherapeutics LLCinto NTN Buzztime, Inc. · Mar 25, 2021
- Chemomab Ltd.into Anchiano Therapeutics Ltd. · Mar 16, 2021